Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroma Security Regulatory News (CSSG)

Share Price Information for Croma Security (CSSG)

Share Price is delayed by 15 minutes
Get Live Data
67.50    0.00 (0.00%)
Bid:
65.00
Ask:
70.00
Spread: 5.00 (7.692%)
Market Cap: £9.29m
CSSG Live PriceLast checked at - London Stock Exchange

Intraday Croma Security Share Chart

Placing and Update

3 Jul 2007 08:00

Croma Group PLC03 July 2007 3 JULY 2007 CROMA GROUP PLC ("Croma" or "the Group") PLACING AND LOAN NOTE CONVERSION TO RAISE £751,263 DIRECTOR DEALING, TRADING UPDATE AND BOARD CHANGES The Board of Croma, the AIM listed surveillance security and homeland defencespecialist, is pleased to announce that it has raised £751,263 through a Placingof 10,000,000 new Ordinary Shares of 5p each at a Placing price of 5p withexisting institutional shareholders and certain Directors ("the Placing") andthe conversion by Sebastian Morley, an Executive Director, of a £251,623convertible loan note in connection with the final instalment for the purchaseof his company Vigilant Security (Scotland) Limited, to provide the Company withadditional working capital to fund organic growth opportunities. As part of the Placing, Nick Hewson, Non-Executive Director, subscribed for1,000,000 new Ordinary Shares, and Sebastian Morley subscribed for 1,000,000 newOrdinary Shares in addition to his Loan Note conversion. Nick Hewson now holds2,374,119 ordinary shares representing approximately 1.4 per cent. of theenlarged issued share capital of the Company and Sebastian Morley and his wifenow holds 14,844,691 ordinary shares representing approximately 8.6 per cent. ofthe enlarged issued share capital of the Company. These share purchases bring the total number of shares held by the Board to17,981,842 representing 10.52 per cent. of the total issued share capital of theGroup. Trading Update The Board anticipates that although turnover will be in excess of £5.5 million(2006: £2.8 million), turnover and profits for the year ended 30 June 2007 willbe below market expectations. The reasons behind the shortfall are principally due to deferred orders notfalling within the current year. The Board however reaffirms that all of Croma'soperating subsidiaries continue to show an improving performance, as highlightedat the time of the Group's Interim Results, with a current order book totaling£2.98 million. Board Changes Following the recent statement by the Group, where it announced that upon theappointment of a suitable replacement, David Bretel is to stand down as FinanceDirector and Company Secretary of the Group to take up a senior appointment asManaging Director of Croma Defence Systems Limited incorporating Croma Shawley,the Company announces that Sebastian Morley has assumed the role as CEO of theGroup. John French will assume the role of Non-Executive Chairman of the Group,working closely with the Board on the development of the activities of Cromafrom a corporate development standpoint. The Group also announces that Keith Wheeler, the Group's Marketing ServicesDirector, has stepped down from the Board but will however continue in aconsultancy role, advising the subsidiary companies. In the opinion of the Board, the operational reorganisation within the Group isexpected to provide opportunities to reduce operating costs moving forward. Commenting, John French said: "I have long expressed the desire to split out mydual role as both Chairman and CEO of the Group. I am delighted that Sebastianhas accepted his new appointment. His complementary military background andsuccessful track record positions him well for the role, and I look ahead todriving the Group forward with him at the commercial helm. "It is highly encouraging to see two of the Group's key InstitutionalShareholders subscribing for new shares. This adds to the further investmentmade by our two Board members. All of Croma's operating subsidiaries continueto show an improving performance, as highlighted at the time of the Group'sInterim Results. "Furthermore, the heightened awareness of the surveillance and homeland securitymarkets supports Croma's vision for the future. There has never been a moreappropriate time for a business of Croma's nature in the market, and the Boardwill continue to look at every possible opportunity to grow value for allshareholders going forward. "I'd also like to thank Keith today for all of his work to date, and delightedhe will remain working alongside the Group in a consultancy role." AIM Application Application has been made for the admission of the 15,025,260 new OrdinaryShares to trading on the AIM market. The new Ordinary Shares will rank paripassu with the existing ordinary shares in the Company and admission of the15,025,260 new ordinary shares is expected to take place on Friday 6 July 2007. Total Voting Rights For the purposes of the Financial Services Authority's Disclosure andTransparency Rules, the Company's total issued share capital at the date of thisnotice is 170,983,173. The Company's issued share capital consists of 170,983,173 ordinary shares of 5peach, with one voting right per share. The Company holds no ordinary shares inTreasury. Therefore, the total number of voting rights in Croma is 170,983,173. The above figure may be used by shareholders as the denominator for thecalculations by which they will determine if they are required to notify theirinterest in, or a change to their interest in, Croma under the FSA's Disclosureand Transparency Rules. ---ends--- Enquiries: Croma Group plcJohn French, Non Executive Chairman Mobile: 07836 722 482 Bishopsgate Communications Ltd. Tel: 020 7562 3350Dominic Barretto Mobile: 07930 450 156Jenni Herbert Seymour Pierce Limited Tel: 020 7107 8000Mark Percy This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Jul 20237:00 amRNSCompletion of the Disposal & Total Voting Rights
30th Jun 20239:32 amRNSResult of General Meeting
6th Jun 20237:00 amRNSProposed Disposal of Vigilant for £6.5 million
28th Apr 20237:00 amRNSDirectorate Change
4th Apr 20237:00 amRNSDirectorate Change
14th Mar 20237:00 amRNSHalf-year Report
20th Jan 20237:00 amRNSDirectorate Change
20th Dec 20227:00 amRNSAcquisition of Safecell Security Group
6th Dec 20223:51 pmRNSResult of AGM
6th Dec 20227:00 amRNSAGM Statement, Potential Divestment, Board Changes
11th Nov 20227:00 amRNSFinal Results
27th Oct 20227:00 amRNSPublication of 2022 Final Results
15th Sep 20227:00 amRNSContract Wins & Trading Update
6th Jul 20227:00 amRNSAcquisition
31st Mar 20225:08 pmRNSDirector/PDMR Shareholding
29th Mar 20222:50 pmRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSHalf-year Report
24th Jan 20227:00 amRNSStrategic Partnership
26th Nov 202112:03 pmRNSGrant of Options, PDMR dealing
24th Nov 20211:36 pmRNSResult of AGM
18th Nov 20217:00 amRNSAcquisition
8th Nov 202112:28 pmRNSHolding(s) in Company
28th Oct 20212:38 pmRNSHolding(s) in Company
21st Oct 20217:00 amRNSFinal Results
6th Oct 202110:54 amRNSHolding(s) in Company
4th Oct 20217:00 amRNSTrading Statement and Strategic Partnership
2nd Jul 20217:44 amRNSHolding(s) in Company
28th Jun 20217:00 amRNSTrading Statement
24th Mar 20217:00 amRNSDirector/PDMR Shareholding
12th Mar 202110:07 amRNSHolding(s) in Company
1st Mar 20217:00 amRNSHalf-year Report
18th Jan 20217:00 amRNSHolding(s) in Company
25th Nov 20201:52 pmRNSResult of AGM
21st Oct 20207:00 amRNSFinal Results
13th Aug 202011:00 amRNSDividend Reinstated and Contract Win
2nd Jul 20207:00 amRNSDirector/PDMR Shareholding
1st Jul 20207:00 amRNSDirector/PDMR Shareholding
15th Jun 20207:00 amRNSContract Renewal and Uplift
8th Jun 20207:00 amRNSTrading Update
4th Jun 20204:40 pmRNSSecond Price Monitoring Extn
4th Jun 20204:35 pmRNSPrice Monitoring Extension
19th Mar 20203:01 pmRNSCancellation of Dividend
2nd Mar 20207:00 amRNSHalf-year Report
4th Feb 20208:12 amRNSHolding(s) in Company
24th Jan 202012:00 pmRNSHolding(s) in Company
27th Nov 20191:32 pmRNSResult of AGM
21st Oct 20197:00 amRNSFinal Results
29th Mar 20196:00 pmRNSHolding(s) in Company
18th Mar 201912:58 pmRNSDirector/PDMR Shareholding
26th Feb 20194:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.